Company: NDRA
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001654954-25-005770
Chunk: 89

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-05-15
Form: 10-Q
Item: Part II, Item 3
Chunk 89
---
15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 ENDRA LIFE SCIENCES INC.    Date: May 15, 2025By:/s/ Alexander Tokman   Alexander Tokman   Chief Executive Officer and Chairman(Principal Executive Officer) 

 ENDRA LIFE SCIENCES INC.     Date: May 15, 2025By:/s/ Richard Jacroux   Richard Jacroux   Chief Financial Officer(Principal Financial and Accounting Officer) 

 24